We are live on ! Find out more
BIOL

Biolase, Inc.
BIOL

Delisted

BIOL was delisted on the 18th of June, 2024.

Back to rankings

32 hedge funds and large institutions have $14.8M invested in Biolase, Inc. in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

380% more capital invested

Capital invested by funds: $3.07M → $14.8M (+$11.7M)

167% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 3

33% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 12

10% more funds holding

Funds holding: 29 → 32 (+3)

Holders
32
Holders Change
+3
Holders Change %
+10.34%
% of All Funds
0.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
8
Reduced
3
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$5.95M
2
BlackRock
BlackRock
New York
+$3.26M
3
Renaissance Technologies
Renaissance Technologies
New York
+$2.01M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$678K
5
PCM
Perkins Capital Management
Minnesota
+$430K

Top Sellers

Rank Fund Capital Flow
1
OIM
Oracle Investment Management
Connecticut
-$725K
2
Squarepoint
Squarepoint
New York
-$489K
3
ICM
Invenomic Capital Management
Massachusetts
-$253K
4
GCP
GSA Capital Partners
United Kingdom
-$82K
5
WPC
White Pine Capital
Minnesota
-$73K
Name Holding Trade Value Shares
Change 		Change in
Stake
WSC
26
Wellington Shields & Co
New York
$8K – – –
SC
27
Scotia Capital
Ontario, Canada
$8K +$9.83K +4 New
SXL
28
Summit X LLC
Missouri
$8K +$9.83K +4 New
TFO
29
Tarbox Family Office
California
$7K – – –
Osaic Holdings
30
Osaic Holdings
Arizona
$3K +$4.92K +2 New
IA
31
IFP Advisors
Florida
$2K – – –
1832 Asset Management
32
1832 Asset Management
Ontario, Canada
$1K – – –
Barclays
33
Barclays
United Kingdom
$1K – – –
IAIM
34
International Assets Investment Management
Florida
$1K – – –
Wells Fargo
35
Wells Fargo
California
$1K – – –
APA
36
American Portfolios Advisors
New York
$341 – – –
OIM
37
Oracle Investment Management
Connecticut
– -$725K -696 Closed
ICM
38
Invenomic Capital Management
Massachusetts
– -$253K -243 Closed
GCP
39
GSA Capital Partners
United Kingdom
– -$82K -78 Closed
WPC
40
White Pine Capital
Minnesota
– -$73K -70 Closed
VF
41
Virtu Financial
New York
– -$60K -57 Closed
TRCT
42
Tower Research Capital (TRC)
New York
– -$29K -28 Closed
SM
43
Sabby Management
Florida
– -$26K -25 Closed
MCM
44
Marathon Capital Management
Maryland
– -$20K -20 Closed
CPO
45
Cerity Partners OCIO
New York
– -$14K -14 Closed
DAS
46
Dynamic Advisor Solutions
Arizona
– -$7K -7 Closed
NSIM
47
North Star Investment Management
Illinois
– -$3K -3 Closed
OIA
48
Optimum Investment Advisors
Illinois
– -$1K -1 Closed
1
2

BIOL Hedge Fund Activity: Q1 2021 in Review

32 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Biolase, Inc. (BIOL) for Q1 2021, worth a combined $14.8M — up 380% from $3.07M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new BIOL positions and 12 closed out — a net gain of 4 holders — while 8 added to existing stakes and 3 trimmed.

The largest buyer was Vanguard Group, adding an estimated $5.95M. The largest seller was Oracle Investment Management, exiting entirely with an estimated $725K sold.

  • 32 institutional investors held Biolase, Inc. (BIOL) as of Q1 2021, up from 29 in Q4 2020.
  • Funds reported $14.8M of Biolase, Inc. stock for Q1 2021, up 380% quarter-over-quarter.
  • 16 funds opened new Biolase, Inc. positions in Q1 2021 and 12 closed out, a net change of +4 holders.
  • The largest Biolase, Inc. buyer in Q1 2021 was Vanguard Group, an estimated $5.95M added.
  • The largest Biolase, Inc. seller in Q1 2021 was Oracle Investment Management, an estimated $725K sold.

Based on aggregated 13F filings for Q1 2021.